Witzig TE - Search Results

1

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo M, Nowakowski GS, Habermann TM, Witzig TE, Micallef IN, Johnston PB, Inwards DJ, Botto B, Ristow KM, Young JR, Vitolo U, Ansell SM. Novo M, et al. Among authors: witzig te. Leuk Lymphoma. 2020 Feb;61(2):318-327. doi: 10.1080/10428194.2019.1663422. Epub 2019 Sep 26. Leuk Lymphoma. 2020. PMID: 31556355

2

Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry. A comparison with the standard frozen-section method.

Witzig TE, Banks PM, Stenson MJ, Griepp PR, Katzmann JA, Habermann TM, Colgan JP, Gonchoroff NJ. Witzig TE, et al. Am J Clin Pathol. 1990 Sep;94(3):280-6. doi: 10.1093/ajcp/94.3.280. Am J Clin Pathol. 1990. PMID: 2204263

3

Rapid S-phase determination of non-Hodgkin's lymphomas with the use of an immunofluorescence bromodeoxyuridine labeling index procedure.

Witzig TE, Gonchoroff NJ, Greipp PR, Katzmann JA, Stenson MJ, Habermann TM, Colgan JP, Therneau TM, Banks PM. Witzig TE, et al. Am J Clin Pathol. 1989 Mar;91(3):298-301. doi: 10.1093/ajcp/91.3.298. Am J Clin Pathol. 1989. PMID: 2646907

4

Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies.

Greipp PR, Witzig TE, Gonchoroff NJ, Habermann TM, Katzmann JA, O'Fallon WM, Kyle RA. Greipp PR, et al. Among authors: witzig te. Mayo Clin Proc. 1987 Nov;62(11):969-77. doi: 10.1016/s0025-6196(12)65066-6. Mayo Clin Proc. 1987. PMID: 3118117

5

Primary renal non-Hodgkin's lymphoma. An unusual extranodal site.

Okuno SH, Hoyer JD, Ristow K, Witzig TE. Okuno SH, et al. Among authors: witzig te. Cancer. 1995 May 1;75(9):2258-61. doi: 10.1002/1097-0142(19950501)75:9<2258::aid-cncr2820750911>3.0.co;2-s. Cancer. 1995. PMID: 7712433 Review.

6

Refractory and relapsing multiple myeloma treated by blood stem cell transplantation.

Gertz MA, Pineda AA, Chen MG, Letendre L, Greipp PR, Solberg LA Jr, Witzig TE, Garton JP, Inwards DJ, Litzow MR, et al. Gertz MA, et al. Among authors: witzig te. Am J Med Sci. 1995 Mar;309(3):152-61. doi: 10.1097/00000441-199503000-00006. Am J Med Sci. 1995. PMID: 7879820

7

Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.

Witzig TE, Weitz JJ, Lundberg JH, Tefferi A. Witzig TE, et al. Leuk Lymphoma. 1994 Jun;14(1-2):137-9. doi: 10.3109/10428199409049659. Leuk Lymphoma. 1994. PMID: 7920220

8

Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest?

Witzig TE, Gertz MA, Lust JA, Kyle RA, Greipp PR. Witzig TE, et al. Leuk Lymphoma. 1995 Nov;19(5-6):417-22. doi: 10.3109/10428199509112199. Leuk Lymphoma. 1995. PMID: 8590841

9

S-phase fraction by the labeling index as a predictive factor for progression and survival in low grade non-Hodgkin's lymphoma.

Witzig TE, Habermann TM, Kurtin PJ, Schroeder G, Stenson MJ, Greipp PR. Witzig TE, et al. Cancer. 1995 Sep 15;76(6):1059-64. doi: 10.1002/1097-0142(19950915)76:6<1059::aid-cncr2820760621>3.0.co;2-e. Cancer. 1995. PMID: 8625208

10

Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.

Hartmann LC, Tschetter LK, Habermann TM, Ebbert LP, Johnson PS, Mailliard JA, Levitt R, Suman VJ, Witzig TE, Wieand HS, Miller LL, Moertel CG. Hartmann LC, et al. Among authors: witzig te. N Engl J Med. 1997 Jun 19;336(25):1776-80. doi: 10.1056/NEJM199706193362502. N Engl J Med. 1997. PMID: 9187067 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters